Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Fresenius Medical Care hit with FDA warning letter at Utah plant
After multiple complaints, a Form 483 and a recall, a Fresenius manufacturing unit in Utah is contending with an FDA warning letter.
Fraiser Kansteiner
Sep 3, 2026 3:31pm
FDA docs shed light on contentious nod for Replimune's Trudiqev
Sep 3, 2026 12:10pm
Why real-world data is becoming a strategic asset in drug development
Brought to you by
LabCorp
Akeso, Summit’s ivonescimab hits OS goal in Keytruda head-to-head
Sep 3, 2026 10:29am
Pharma Doesn't Have an AI Problem. It Has an Information Problem.
Brought to you by
Intelligencia AI
ESC: Amgen CMO touts Repatha 'inflection' on mortality data
Sep 3, 2026 8:30am
